XML 29 R15.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 9 - Income Taxes
12 Months Ended
Dec. 25, 2021
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

(9) Income Taxes

 

Components of income tax expense (benefit) for each year are as follows:

 

  

2021

  

2020

 

Current:

        

Federal

 $--  $(39,877)

State

  11,967   456 
         

Current income tax provision (benefit):

  11,967   (39,421)
         

Deferred:

        

Federal

  (2,156,278)  33,873 

State

  (562,667)  (3,000)
         

Deferred income tax provision (benefit), net

  (2,718,945)  30,873 
         

Total

 $(2,706,978) $(8,548)

 

Deferred tax assets as of December 25, 2021 and December 26, 2020 are as follows:

 

  

December 25, 2021

  

December 26, 2020

 

Deferred Tax Assets:

        

Net operating loss carryforwards

 $1,050,449  $746,397 

Stock compensation

  157,845   540,281 

Credit carryforwards

  1,285,119   1,288,897 

Inventory

  77,563   116,153 

Accrued liabilities

  12,390   22,140 

Depreciation

  237,880   250,093 

Other

  2,732   2,732 

Gross deferred tax assets

  2,823,978   2,966,693 

Valuation allowance

  0   (2,849,693)

Net deferred tax assets

 $2,823,978  $117,000 

 

At December 25, 2021 and December 26, 2020 the Company had net operating loss carryforwards of approximately $3,768,032 and $2,754,601, respectively, available to offset future income for U.S. Federal income tax purposes. These net operating loss carryforwards occurred over several years, which begin to expire in the year ended 12/31/2036.

 

The Company established a valuation reserve as it is judged more likely than not that all or a portion of the tax credits will not be used before they expire. This decision was initially reached in 2018 after giving greater weight to its losses over the last three years compared with its forecast of the future.

 

In September 2021 this decision was reevaluated in light of the Company’s recent profitability and its forecasts for future profitability. The Company concluded that it is “more likely than not” that the Company will be able to fully utilize the deferred tax asset. This reversal of the valuation allowance was made net of the expected tax liability for 2021.

 

A summary of the change in the deferred tax asset is as follows:

 

  

2021

  

2020

 
         

Gross deferred tax balance at beginning of year

 $2,966,693  $3,321,611 
         

Deferred tax benefit (provision)

  (142,715)  (354,918)

Valuation allowance

  0   (2,849,693)

Balance at end of year, net

 $2,823,978  $117,000 

 

Income tax expense is different from the amounts computed by applying the U.S. federal statutory income tax rate of 21 percent to pretax income as a result of the following:

 

  

2021

  

2020

 
         

Tax at statutory rate

 $106,869  $188,899 

State tax, net of federal benefit

  36,301   360 
         

Net operating loss and credit carryforwards

  --   33,873 
         

Valuation allowance

  (2,849,693)  (324,045)
         

Other

  (455

)

  92,365 
         

Total

 $(2,706,978) $(8,548)

 

The Company’s income tax filings are subject to review and examination by federal and state taxing authorities. The Company is currently open to audit under the applicable statutes of limitations for the years 2018 through 2021.